2012
DOI: 10.2174/092986712803988866
|View full text |Cite
|
Sign up to set email alerts
|

Yersinia pestis and Approaches to Targeting its Outer Protein H Protein-Tyrosine Phosphatase (YopH)

Abstract: Plague is an infectious disease with a high mortality rate that has repeatedly impacted human society. It remains a threat in many parts of the world today. Plague is caused by the bacterium, Yersinia pestis (Y. pestis), which has as one of its required virulence factors, the protein-tyrosine phosphatase, YopH. Therefore, YopH represents a potential target for the treatment of Y. pestis infection. Recent recognition of Y. pestis as a possible bioterrorism agent and the fact that it is still the cause of endemi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 84 publications
(137 reference statements)
0
7
0
Order By: Relevance
“…The crystal structure of YopH indicates that its N- and C-terminal domains are linked by a proline-rich sequence. The N-terminal domain contains a type III secretion signal, a chaperon-binding region and a substrate-binding domain (Khandelwal et al, 2002), while the C-terminal domain includes a PTPase catalytic domain and an additional substrate-binding domain (Phan et al, 2003; Bahta and Burke, 2012). These two substrate recognition domains cooperate to reinforce binding of YopH to its substrate and enhance its activity and virulence.…”
Section: Antiphagocytic Factormentioning
confidence: 99%
“…The crystal structure of YopH indicates that its N- and C-terminal domains are linked by a proline-rich sequence. The N-terminal domain contains a type III secretion signal, a chaperon-binding region and a substrate-binding domain (Khandelwal et al, 2002), while the C-terminal domain includes a PTPase catalytic domain and an additional substrate-binding domain (Phan et al, 2003; Bahta and Burke, 2012). These two substrate recognition domains cooperate to reinforce binding of YopH to its substrate and enhance its activity and virulence.…”
Section: Antiphagocytic Factormentioning
confidence: 99%
“…While drug-design efforts targeting PTKs have resulted in the development of many inhibitors that are used in the clinic today, medicinal chemistry efforts targeting PTPs lag far behind and remain very challenging. Nevertheless, several PTPs have the potential to serve as important drug targets for a variety of diseases such as cancer, diabetes, neurological and autoimmune disorders, inflammation and numerous pathogenic infections (Blaskovich, 2009;Bialy & Waldmann, 2005;Tautz et al, 2006;Alonso et al, 2004;Mustelin, 2006;Bahta & Burke, 2012;Guan & Dixon, 1993;Zhou et al, 2010;Bö hmer et al, 2013). PTPs are generally considered to be difficult targets for therapeutic intervention, in part because of their highly conserved active sites.…”
Section: Introductionmentioning
confidence: 99%
“…Yersinia sp . utilizes a type III secretion system for translocation of virulence effectors into the host cell [ 3 ]. All three Yersinia species contain a 70kb plasmid that encodes a type III complex system and effectors (Yops).…”
Section: Introductionmentioning
confidence: 99%